News

ManchesterWorld on MSN7d
Disabled Oldham man with MS takes on charity skydive
An Oldham man whose multiple sclerosis (MS) left him unable to pick himself up off the floor is jumping out of a plane this ...
pharmaphorum29d
Regulators finally back Merck KGaA oral MS drug
Europe’s CHMP top scientific committee gave a positive opinion for approval to cladribine, with the proposed trade name Mavenclad, for relapsing forms of MS with high disease activity.
NHS England29d
Thousands of NHS patients to benefit from ‘take at home’ multiple sclerosis tablet in European first
Laura Thomas, Head of Policy at the MS Society, said: “It’s great news that NICE have recommended the disease modifying treatment (DMT) cladribine (Mavenclad) as an option for those with active ...
STV News1mon
Medicines regulator considers wider rollout of take-at-home tablet for MS
The Scottish Medicines Consortium is reviewing cladribine for broader use in relapsing forms of the condition.
ITV1mon
Take-at-home tablet for MS approved by NHS
The health service is thought to be the first in Europe to widely rollout cladribine, also known as Mavenclad and made by Merck. It has been approved by the National Institute for Health and Care ...
The Independent1mon
Take-at-home tablet for MS approved for wider NHS rollout
The health service is thought to be the first in Europe to widely rollout cladribine, also known as Mavenclad and made by Merck. It has been approved by the National Institute for Health and Care ...
Northwich Guardian1mon
Take-at-home tablet for MS approved for wider NHS rollout
The health service is thought to be the first in Europe to widely rollout cladribine, also known as Mavenclad and made by Merck. It has been approved by the National Institute for Health and Care ...